 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
1-10-2025
Insider Buy |
Gary Sender
Director |
$2.72
CAGR »
|
$24,999.52
9,191 shares |
1-10-2025
Insider Buy |
Antonio Bernardino Guimaraes Parada
Director |
$2.72
CAGR »
|
$499,998.56
183,823 shares |
1-10-2025
Insider Buy |
William D. Clark
Director |
$2.72
CAGR »
|
$4,999.36
1,838 shares |
1-10-2025
Insider Buy |
David Arkowitz
Director |
$2.72
CAGR »
|
$49,999.04
18,382 shares |
1-10-2025
Insider Buy |
Marc Banjak
Chief Legal Officer |
$2.72
CAGR »
|
$24,999.52
9,191 shares |
1-10-2025
Insider Buy |
Martin Brenner
See Remarks |
$2.72
CAGR »
|
$24,999.52
9,191 shares |
1-10-2025
Insider Buy |
Felipe Duran
Chief Financial Officer |
$2.72
CAGR »
|
$24,999.52
9,191 shares |
7-12-2018
Insider Buy |
Capital Ltd Eastern
>10% Owner |
$0.90
CAGR »
|
$1,980,000.00
2,200,000 shares |
6-26-2018
Insider Buy |
Capital Ltd Eastern
>10% Owner |
$0.90
CAGR »
|
$1,515,000.60
1,683,334 shares |
4-7-2016
Insider Buy |
Capital Ltd Eastern
>10% Owner |
$0.62
CAGR »
|
$4,043,000.00
6,500,000 shares |
1-25-2016
Insider Buy |
Capital Ltd Eastern
>10% Owner |
$0.62
CAGR »
|
$2,177,000.00
3,500,000 shares |
Also See: Institutional Holders of IBIO
Also See: SEC filings
Below we present the annualized performance delivered by IBIO stock since 1-10-2025 (the date of the most recent
insider purchase). The performance of the investment from the time IBIO insider buying occurred is the ultimate
test of whether insiders were right about IBIO being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/13/2025 |
|
| End date: |
03/21/2025 |
|
| Start price/share: |
$2.48 |
|
| End price/share: |
$4.63 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
86.69% |
|
| Annualized Gain: |
479.44% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$18,669.00 |
|
| Years: |
0.18 |
|
IBIO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent IBIO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding IBIO
|
|
Free IBIO Email Alerts:
